Page last updated: 2024-09-04

cgs 26303 and Brain Edema

cgs 26303 has been researched along with Brain Edema in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chang, CZ; Howng, SL; Jeng, AY; Kassell, NF; Kwan, AL; Lin, TK; Winadi, D; Wu, SC; Yen, CP1

Other Studies

1 other study(ies) available for cgs 26303 and Brain Edema

ArticleYear
Neuroprotective effect of CGS 26303, an endothelin-converting enzyme inhibitor, on transient middle cerebral artery occlusion in rats.
    Journal of cardiovascular pharmacology, 2004, Volume: 44 Suppl 1

    Topics: Animals; Aspartic Acid Endopeptidases; Behavior, Animal; Brain; Brain Edema; Disease Models, Animal; Drug Administration Schedule; Endothelin-Converting Enzymes; Infarction, Middle Cerebral Artery; Injections, Intravenous; Male; Metalloendopeptidases; Neuroprotective Agents; Organophosphonates; Protease Inhibitors; Rats; Rats, Sprague-Dawley; Tetrazoles

2004